Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Clostridioides (Clostridium) difficile & Colorectal Cancer (CRC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Chronic infection with the enteric pathogen Clostridioides (Clostridium) difficile is a previously unrecognized contributor to colonic tumorigenesis
Drewes et al. 2022 Cancer Discov 12: 1873-85

Clostridioides (Clostridium) difficile strains isolated from human Colorectal Cancer (CRC) mucosa drive colonic tumor formation in [GF Apc Min/+mice](brain://8nq0WWmO3kW3vKOp5yzGOw/GermfreeGfApcMinM…

Clostridioides difficile antibody response of colorectal cancer patients versus clinically healthy individuals
Magat et al. 2020
Clostridium difficile colonization in preoperative colorectal cancer patients
Zheng et al. 2017 Oncotarget 8: 11877-11886
High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients
Fukugaiti et al. 2015 Braz J Microbiol 46: 1135-1140
Human Colon Cancer–Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in Mice
Drewes et al. 2022 Cancer Discov 12: 1873-85
Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan
Hsieh et al. 2018 Sci Rep 8: 158
Inferring bacterial infiltration in primary colorectal tumors from host whole genome sequencing data
Guo et al. 2019c Front Genet 10: 213

7/1/2026